Literature DB >> 11207976

Microsporum canis tinea capitis in an 8-month-old infant successfully treated with 2 weekly pulses of oral itraconazole.

E Koumantaki1, S Georgala, E Rallis, E Papadavid.   

Abstract

We report an 8-month-old girl with tinea capitis caused by Microsporum canis which was successfully treated with two pulses of oral itraconazole 50 mg/day, each of 1 week duration with an interval of 2 weeks. M. canis tinea capitis can be a difficult therapeutic problem in an infant, as the treatment is usually long, lasting up to 4-6 weeks with griseofulvin and 6-12 weeks with terbinafine, and the desire to provide a safe systemic therapy is particularly important. With an intermittent regimen the duration of treatment with active drug can be much shorter compared to continuous therapy. We found that itraconazole pulse therapy for M. canis tinea capitis was a safe and effective treatment in an infant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207976     DOI: 10.1046/j.1525-1470.2001.018001060.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Tinea capitis in infants: recognition, evaluation, and management suggestions.

Authors:  Brent D Michaels; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-02

2.  Annular, erythematous skin lesions in a neonate.

Authors:  Aparna Palit; Arun C Inamadar
Journal:  Indian Dermatol Online J       Date:  2012-01

Review 3.  Efficacy and safety of itraconazole use in infants.

Authors:  Shuang Chen; Kai-Yi Sun; Xiao-Wei Feng; Xin Ran; Jebina Lama; Yu-Ping Ran
Journal:  World J Pediatr       Date:  2016-06-10       Impact factor: 9.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.